newsfilter
← Latest News
GlobeNewswire·

Aravive To Participate in Piper's 34th Annual Healthcare Conference

HOUSTON, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Aravive, Inc. (NASDAQ:ARAV), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced that Gail McIntyre, Ph.D.,